Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro-Reference-Cited by-同舟云学术

Anti-neoplastic effect of protein kinase CK2 inhibitor, 2-dimethylamino-4,5,6,7-tetrabromobenzimidazole (DMAT), on growth and hormonal activity of human adrenocortical carcinoma cell line (H295R) in vitro

Published:2010-04-06 Issue:2 Volume:340 Page:371-379
ISSN:0302-766X
Container-title:Cell and Tissue Research
language:en
Short-container-title:Cell Tissue Res

Author:

Lawnicka Hanna,Kowalewicz-Kulbat Magdalena,Sicinska Paulina,Kazimierczuk Zygmunt,Grieb Pawel,Stepien Henryk

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00441-010-0960-1.pdf

Reference46 articles.

1. Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X, Bertherat J (2006) Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 91:2650–2655

2. Ahlman H, Khorram-Manesh A, Jansson S, Wängberg B, Nilsson O, Jacobsson CE, Lindstedt S (2001) Cytotoxic treatment of adrenocortical carcinoma. World J Surg 25:927–933

3. Ahmad KA, Wang G, Slaton J, Unger G, Ahmed K (2005) Targeting CK2 for cancer therapy. Anticancer Drugs 16:1037–1043

4. Ahmad KA, Wang G, Unger G, Slaton J, Ahmed K (2008) Protein kinase CK2—a key suppressor of apoptosis. Adv Enzyme Regul 48:179–187

5. Ahmed K, Gerber DA, Cochet C (2002) Joining the cell survival squad: an emerging role for protein kinase CK2. Trends Cell Biol 12:226–230

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CK2 inhibitor DMAT ameliorates spinal cord injury by increasing autophagy and inducing anti-inflammatory microglial polarization;Neuroscience Letters;2023-05

2. Antitumor activity of the protein kinase inhibitor 1-(β-D-2′-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines;BMC Cancer;2022-10-15

3. CK2 and protein kinases of the CK1 superfamily as targets for neurodegenerative disorders;Frontiers in Molecular Biosciences;2022-10-06

4. Inhibiting CK2 among Promising Therapeutic Strategies for Gliomas and Several Other Neoplasms;Pharmaceutics;2022-01-30

5. Novel small molecule protein kinase CK2 inhibitors exert potent antitumor effects on T98G and SEGA cells in vitro;Folia Neuropathologica;2019